Shining a light on the life sciences
The OBN Awards struck an optimistic tone as the best of the UK’s life sciences industry was celebrated
CrestOptics and Tomocube partner to advance 3D imaging with new multimodal imaging platform
First commercially available spinning-disk confocal holotomographic instrument, enabling advanced 3D imaging with fluorescence-based detection
Tagomics announces a multiomic profiling co-marketing agreement with Agilent
Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis
Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line
Strategic agreement will accelerate the manufacturing of fully human multispecific therapies for chronic retinal diseases with high unmet need using Asimov’s CHO Edge System
Steritas announces collaboration with argenx to advance evidence for novel steroid-sparing therapeutics
First-in-class steroid-toxicity outcome assessments licensed by argenx to support development of novel steroid-sparing therapeutics for autoimmune diseases
Enterprise Therapeutics publishes on medicinal chemistry of ETD001, a novel inhaled ENaC blocker for treatment of cystic fibrosis
Paper in the European Journal of Medicinal Chemistry discloses the optimisation process leading to the selection for development of ETD001, an inhaled ENaC blocker with a best-in-class profile
Sapio Sciences collaborates with Waters Corporation to improve efficiency of laboratory operations
The advanced connectivity of Sapio LIMS with waters_connect for Quantitation liquid chromatography mass spectrometry (LC-MS) software
Mursla Bio’s EvoLiver surpasses current standards in liver cancer surveillance, data presented at AASLD Liver Meeting 2024
EvoLiver™ demonstrated 86% early-stage sensitivity at 88% specificity for liver cancer surveillance among cirrhotic, high-risk patients with diverse etiologies Validates clinical value of multi
Bio-Rad demonstrates leadership position in the oncology market at Association for Molecular Pathology 2024
Strength of ddPCR™ Products, Including IVDR Certification, Strategic Collaborations in Molecular Residual Disease Monitoring, and Large Methylation Assay Library, Support Company’s Oncology Strategy
Mursla Bio joins leading European consortium to advance clinical applications based on extracellular vesicle science
Selected to support scaling and commercialization strategy for extracellular vesicle-based disease surveillance and diagnostics Consortium funded by Horizo
SolasCure and U.S. Army Institute of Surgical Research collaborate for combat wound care
The collaboration will evaluate Aurase Wound Gel for the treatment of infected wounds in combat field care scenariosCambridge, UK and Texas, USA, 06
Sapio Sciences expands collaboration with AWS to advance science-aware AI vision
Collaboration enables customers to securely and confidently use AI to accelerate drug research and discovery
VALANX Biotech and Fina Biosolutions introduce ClickCRM for rapid conjugate vaccine development
Joint licensing agreement to commercialize ready-to-conjugate vaccine carrier protein CRM197 will enable rapid development of conjugate vaccines
Kadans Science Partner breaks ground at new purpose-built commercial science facilities at Merlin Place, North Cambridge
Breaking ground ceremony brings together key stakeholders to celebrate progress in development of new bespoke laboratory facilities Late
Calluna Pharma successfully completes Phase 1 clinical study of CAL101, a first-in-class therapeutic for fibrotic and fibro-inflammatory indications
CAL101 is an anti-S100A4 monoclonal antibody (mAb) and Calluna’s lead drug candidate
Ellison Institute of Technology Los Angeles Accelerates Cancer Research with Sapio LIMS
Innovative research institute streamlines operations and enhances collaboration with unified laboratory informatics platform
Axol Bioscience acquires Phenocell to advance human disease models
Acquisition expands Axol’s iPSC-derived cell models and service offering to include ophthalmology and dermatologyCAMBRIDGE / EDINBURGH, UK, and GRASSE, FRANCE, 21 October 20
Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities
Enhancements support ADA and NAb testing workflows, boosting lab efficiency and regulatory compliance for drug development
Shift Bioscience raises $16M to advance cell simulation AI platform
Investment led by BGF, with support from existing investors F-Prime Capital, Kindred Capital, and Jonathan Milner
Antiverse raises £3.5M ($4.6M) to advance generative AI antibody design platform
Increases total equity financing raised to £7.2M ($10.1M) New facilities in Boston and Prague will provide increased capacity to deliver pipeline of pharm
Alleo and Ubiquigent enter AI-driven strategic partnership to accelerate DUB-focused drug discovery
Collaboration will combine Alleo’s AI-based platform with Ubiquigent’s expertise in the DUB space to advance DUB-focused preclinical programmes
Calluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board
Executive appointments will drive growth strategy and progression of clinical pipeline
Bio-Rad launches high-precision Vericheck ddPCR Empty-Full Capsid Kit to advance development of safe and effective gene therapies
Vericheck ddPCR Empty-Full Capsid Kit Combines Measuring Viral Titer and Capsid Titer, Providing a High-Precision Assessment for Critical Quality Attributes of Both Protein and DNA in Droplets
Mosaic Therapeutics appoints Dr Barry Davies as CSO
Former AstraZeneca Senior Director, Global Project Leader adds significant experience and expertise to leadership team Appointment will drive further development of Mosaic’s targeted oncology